Reporte zur Charge GJ67429

Symptomtext

COVID 19 Treatment; COVID 19 Treatment; Interchange of COVID Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.1 (BNT162B2, BNT162B2 OMI BA.1), on 20Jan2023 at 12:00 as dose 6 (booster), single (Lot number: GJ67429) at the age of 52 years, in right arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 22Mar2021 at 12:00 as dose 1, single (Lot number: ER8727), in right arm, on 12Apr2021 at 12:00 as dose 2, single (Lot number: ER8729), in right arm, on 18Oct2021 at 12:00 as dose 3 (booster), single (Lot number: FF2593), in right arm and on 01Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FM0698), in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 07Sep2022 at 12:00 as dose 5 (booster), single (Lot number: AS7144B) and on 16Sep2023 at 12:00 as dose 7 (booster), single (Lot number: NOVO3030371), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing), notes: managed with treatment.; "high cholesterol" (unspecified if ongoing), notes: managed with treatment. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 07Sep2022 at 12:00, outcome "unknown", described as "Interchange of COVID Vaccine"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Negative, notes: tested negative on day 9 after symptoms; (2023) Positive, notes: tested positive on day 11. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.